檢索結果 - Stuart H. Isaacson
- Showing 1 - 14 results of 14
-
1
-
2
Corrigendum to “Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease” [Clin. Parkinsonism Related Dis. 9... 由 Bruno Bergmans, Veronica Clark, Stuart H. Isaacson, Tobias Bäumer
發表在 Clinical Parkinsonism & Related Disorders (2024-01-01)獲取全文
Article -
3
-
4
-
5
Retrospective analyses evaluating the mortality risk associated with pimavanserin or other atypical antipsychotics in patients with Parkinson disease psychosis 由 Stuart H. Isaacson, Rajesh Pahwa, Fernando Pagan, Victor Abler, Daniel Truong
發表在 Clinical Parkinsonism & Related Disorders (2024-01-01)獲取全文
Article -
6
-
7
-
8
-
9
-
10
Post hoc exploratory analysis of the effect of foslevodopa/foscarbidopa continuous subcutaneous infusion on nocturia in patients with Parkinson’s disease 由 K. Ray Chaudhuri, Manon Bouchard, Eric Freire-Alvarez, Rajesh Pahwa, Lars Bergmann, Resmi Gupta, Pavnit Kukreja, Megha B. Shah, Stuart H. Isaacson
發表在 Clinical Parkinsonism & Related Disorders (2025-01-01)獲取全文
Article -
11
Apomorphine titration with and without anti-emetic pretreatment in patients with Parkinson’s disease experiencing OFF episodes: A modified Delphi panel 由 Stuart H. Isaacson, Richard Dewey, Robert A. Hauser, Daniel Kremens, Rajeev Kumar, Mark Lew, William Ondo, Fernando Pagan, Kelly E. Lyons, Rajesh Pahwa
發表在 Clinical Parkinsonism & Related Disorders (2024-01-01)獲取全文
Article -
12
AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions 由 Mark F. Lew, Robert A. Hauser, Stuart H. Isaacson, Daniel Truong, Atul T. Patel, Allison Brashear, William Ondo, Pascal Maisonobe, Khashayar Dashtipour, Laxman Bahroo, Stefan Wietek
發表在 Clinical Parkinsonism & Related Disorders (2021-01-01)獲取全文
Article -
13
Long-Term Safety and Efficacy of Repeated Cycles of RimabotulinumtoxinB in the Treatment of Chronic Sialorrhea: Results of the OPTIMYST Trial 由 Rajesh Pahwa, Eric Molho, Mark Lew, Khashayar Dashtipour, Ramon A. Gil, Fredy J. Revilla, Thomas Clinch, Peibing Qin, Stuart H. Isaacson, on behalf of the OPen Label Trial of Intraglandular MYobloc injections for Sialorrhea Treatment (OPTIMYST) study group
發表在 Neurology and Therapy (2025-06-01)獲取全文
Article -
14
LIPAD (LRRK2/Luebeck International Parkinson's Disease) Study Protocol: Deep Phenotyping of an International Genetic Cohort 由 Tatiana Usnich, Eva-Juliane Vollstedt, Nathalie Schell, Volha Skrahina, Xenia Bogdanovic, Hanaa Gaber, Toni M. Förster, Andreas Heuer, Natalia Koleva-Alazeh, Ilona Csoti, Ayse Nazli Basak, Sibel Ertan, Gencer Genc, Peter Bauer, Katja Lohmann, Anne Grünewald, Emma L. Schymanski, Joanne Trinh, Susen Schaake, Daniela Berg, Doreen Gruber, Stuart H. Isaacson, Andrea A. Kühn, Brit Mollenhauer, David J. Pedrosa, Kathrin Reetz, Esther M. Sammler, Enza Maria Valente, Franco Valzania, Jens Volkmann, Simone Zittel, Norbert Brüggemann, Norbert Brüggemann, Meike Kasten, Meike Kasten, Arndt Rolfs, Christine Klein, The LIPAD Study Group
發表在 Frontiers in Neurology (2021-08-01)獲取全文
Article
